Northern Trust Corp Maxcyte, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Maxcyte, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 860,251 shares of MXCT stock, worth $3.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

860,251

Previous 769,951 11.73%

Holding current value

$3.5 Million

Previous $3.02 Million 10.87%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.68 - $5.06 $332,304 - $456,917	90,300 Added 11.73%	860,251 $3.35 Million
Q2 2024 Aug 14, 2024	SELL	$3.63 - $5.0 $60,940 - $83,940	-16,788 Reduced 2.13%	769,951 $3.02 Million
Q1 2024 May 14, 2024	SELL	$3.94 - $5.38 $32,887 - $44,906	-8,347 Reduced 1.05%	786,739 $3.3 Million
Q4 2023 Feb 13, 2024	SELL	$2.6 - $5.24 $6,414 - $12,927	-2,467 Reduced 0.31%	795,086 $3.74 Million
Q3 2023 Nov 13, 2023	BUY	$3.02 - $5.1 $57,147 - $96,507	18,923 Added 2.43%	797,553 $2.49 Million
Q2 2023 Aug 11, 2023	BUY	$3.69 - $5.35 $63,785 - $92,480	17,286 Added 2.27%	778,630 $3.57 Million
Q1 2023 May 15, 2023	BUY	$4.03 - $5.89 $28,657 - $41,883	7,111 Added 0.94%	761,344 $3.77 Million
Q4 2022 Feb 13, 2023	BUY	$4.92 - $7.4 $9,259 - $13,926	1,882 Added 0.25%	754,233 $4.12 Million
Q3 2022 Nov 14, 2022	BUY	$4.52 - $6.51 $629,238 - $906,270	139,212 Added 22.7%	752,351 $4.89 Million
Q2 2022 Aug 12, 2022	SELL	$3.59 - $6.81 $373,783 - $709,043	-104,118 Reduced 14.52%	613,139 $2.9 Million
Q1 2022 May 13, 2022	BUY	$5.26 - $10.84 $80,741 - $166,394	15,350 Added 2.19%	717,257 $5.01 Million
Q4 2021 Feb 08, 2022	BUY	$8.87 - $12.94 $5.23 Million - $7.62 Million	589,111 Added 522.28%	701,907 $7.15 Million
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $1.38 Million - $1.94 Million	112,796 New	112,796 $1.38 Million

Others Institutions Holding MXCT

# of Institutions

124

Shares Held

65.6M

Call Options Held

Put Options Held

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $414M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Maxcyte, Inc. Transaction History